Diamed Center operates five laboratories, two medical clinics, a medical recovery and aesthetic medicine center, and eight blood collection centers in Bucharest, Braila, Tecuci and Focsani. The company’s representatives estimate an annual turnover of EUR800,000.
“2016 will be another peak year for MedLife in terms of acquisitions, a development project that will be strongly accelerated this year. While in the last 12 months, we completed six local transactions with investments topping EUR5 million, the budget for acquisitions will significantly increase this year, targeting the consolidation of leader position at national level, the diversification of service portfolio and the improvement of operations on the existing business segments,” said Mihai Marcu, Chairman of MedLife’s Executive Board.
In 2010, MedLife bought 80% in the group Policlinica de Diagnostic Rapid in Brasov. The acquisition topped EUR3 million and is the largest operation for the purchase of a local medical services provider in Romania by another local medical services operator. The transaction was followed by two more acquisitions involving Diagnosys Arad and Eva maternity hospital in Brasov.
Last year, MedLife acquired a 55% stake in the group of firms Centrul Medical SAMA and Ultratest, one of the largest medical operators in southwestern Romania, acquired a new imagistic center, Prima Medical, based in Craiova, fully acquired two laboratories in Iasi and Constanta and started the process of acquiring a majority interest in stem cells bank Stem Cells Bank.
MedLife has been operating on the Romanian market since 1996 and currently has 15 clinics, 23 laboratories, ten hospitals, 32 GP medical centers, 14 centers of excellence, eight PharmaLife Med drugstores and partnerships with 140 medical clinics across the country.